Vancouver, BC & Edinburgh, Scotland — October 7, 2025 — Leads & Copy — Humanoid Global Holdings Corp. (CSE:ROBO, FWB:0XM1, OTCQB:RBOHF) announced an update from RideScan Ltd, highlighting the filing of its foundational patent application with the United Kingdom Intellectual Property Office, seeking to protect its approach to risk scoring and anomaly detection in robotics.
RideScan is also entering pilot deployments across various robotics ecosystems to demonstrate its AI-driven insights into robot health and performance. RideScan has also secured £50,000 from the Innovate UK Growth Catalyst Early Stage grant and an additional £40,000 investment from a European deep-tech angel syndicate.
Dr. Nandakumar, CEO of RideScan, stated that the patent marks a major step, and the pilots should show how this innovation can help transform robot deployments. Shahab Samimi, CEO of Humanoid Global, believes this progress fortifies their portfolio’s focus on safe, scalable robotics.
RideScan is also assembling a cohort of 10 organizations to integrate RideScan’s API across robotics platforms to demonstrate the ability to reduce downtime, enhance safety, and uncover hidden anomalies.
Shahab Samimi
Chief Executive Officer
finance@humanoidglobal.ai
info@humanoidglobal.ai
(604) 602-0001
Source: Humanoid Global Holdings Corp.
